metaMe Health Receives FDA Clearance for Regulora®, the First FDA-authorized Treatment Specifically for Abdominal Pain Due to Irritable Bowel Syndrome (IBS)

Chicago, Illinois (PRWEB) November 30, 2021 -- metaMe Health, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for

Related Keywords

United States ,J Clin Hypn ,Olafur Palsson ,Neil Sengupta ,Tim Rudolphi ,Division Of Gastroenterology ,International Foundation For Gastrointestinal Disorders ,Sme Health ,Drug Administration ,University Of Chicago Pritzker School Medicine ,University Of North Carolina ,Me Health Inc ,Gastrointestinal Society ,Bowel Syndrome ,Assistant Professor ,Chicago Pritzker School ,Irritable Bowel Syndrome ,International Foundation ,Gastrointestinal Disorders ,Facts About ,Impact Report ,Prescription Digital Therapeutics ,Digital Therapeutics ,Press Release ,